MCUJF: An interesting find, ronpopeil. Can you provide any details of your investigation(s) on the co., AGGRASTAT, or their development drug(s) that you think make for a compelling investment opportunity here. I did a cursory search and cannot find whether or not AGGRASTAT is patent protected and/or how long it will be. The drug appears to have been around for some time. One study (2001) of head to head comparison with another Platelet Glycoprotein IIb/IIIa Inhibitor found that AGGRASTST was inferior to the compared medication (abciximab), even though the study was designed for simple non-inferiority.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.